Selected research
Industry Research
Recombinant Human BMP-2 Industry Research Report 2026
Market perspective
The global Recombinant Human BMP-2 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Recombinant Human BMP-2 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Recombinant Human BMP-2 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Recombinant Human BMP-2 include 赛默飞世尔, Yeasen Biotechnology (Shanghai), Yantai Zhenghai Bio-Tech, Abbkine Scientific, WEIGAO, Shanghai Zhong Qiao Xin Zhou Biotechnology, Shanghai NovoPro, HANGZHOU JIUYUAN GENE ENGINEERIN and Beijing Baiaolaibo Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Recombinant Human BMP-2 market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Recombinant Human BMP-2 Market by Company
赛默飞世尔
Yeasen Biotechnology (Shanghai)
Yantai Zhenghai Bio-Tech
Abbkine Scientific
WEIGAO
Shanghai Zhong Qiao Xin Zhou Biotechnology
Shanghai NovoPro
HANGZHOU JIUYUAN GENE ENGINEERIN
Beijing Baiaolaibo Technology
STEMCELL Technologies
Sigma Aldrich
Proteintech
CUSABIO TECHNOLOGY
Cgbio
Cell Guidance Systems
Biomol GmbH
Recombinant Human BMP-2 Segment by Type
Powder
Sponge
Others
Recombinant Human BMP-2 Segment by Application
Hospital
Research Institute
Others
Recombinant Human BMP-2 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human BMP-2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human BMP-2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human BMP-2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Recombinant Human BMP-2 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Recombinant Human BMP-2 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Recombinant Human BMP-2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Sponge
- Others
Applications
- Hospital
- Research Institute
- Others
Companies covered
- 赛默飞世尔
- Yeasen Biotechnology (Shanghai)
- Yantai Zhenghai Bio-Tech
- Abbkine Scientific
- WEIGAO
- Shanghai Zhong Qiao Xin Zhou Biotechnology
- Shanghai NovoPro
- HANGZHOU JIUYUAN GENE ENGINEERIN
- Beijing Baiaolaibo Technology
- STEMCELL Technologies
- Sigma Aldrich
- Proteintech
- CUSABIO TECHNOLOGY
- Cgbio
- Cell Guidance Systems
- Biomol GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Recombinant Human BMP-2 Market Size (2021-2032)
- 2.2.2 Global Recombinant Human BMP-2 Sales (2021-2032)
- 2.2.3 Global Recombinant Human BMP-2 Market Average Price (2021-2032)
- 2.3 Recombinant Human BMP-2 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder
- 2.3.3 Sponge
- 2.3.4 Others
- 2.4 Recombinant Human BMP-2 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Research Institute
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Recombinant Human BMP-2 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Recombinant Human BMP-2 Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Recombinant Human BMP-2 Revenue of Manufacturers (2021-2026)
- 3.4 Global Recombinant Human BMP-2 Average Price by Manufacturers (2021-2026)
- 3.5 Global Recombinant Human BMP-2 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Recombinant Human BMP-2, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Recombinant Human BMP-2, Product Type & Application
- 3.8 Global Manufacturers of Recombinant Human BMP-2, Established Date
- 3.9 Global Recombinant Human BMP-2 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 赛默飞世尔
- 4.1.1 赛默飞世尔 Company Information
- 4.1.2 赛默飞世尔 Business Overview
- 4.1.3 赛默飞世尔 Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio
- 4.1.5 赛默飞世尔 Recent Developments
- 4.2 Yeasen Biotechnology (Shanghai)
- 4.2.1 Yeasen Biotechnology (Shanghai) Company Information
- 4.2.2 Yeasen Biotechnology (Shanghai) Business Overview
- 4.2.3 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio
- 4.2.5 Yeasen Biotechnology (Shanghai) Recent Developments
- 4.3 Yantai Zhenghai Bio-Tech
- 4.3.1 Yantai Zhenghai Bio-Tech Company Information
- 4.3.2 Yantai Zhenghai Bio-Tech Business Overview
- 4.3.3 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio
- 4.3.5 Yantai Zhenghai Bio-Tech Recent Developments
- 4.4 Abbkine Scientific
- 4.4.1 Abbkine Scientific Company Information
- 4.4.2 Abbkine Scientific Business Overview
- 4.4.3 Abbkine Scientific Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Abbkine Scientific Recombinant Human BMP-2 Product Portfolio
- 4.4.5 Abbkine Scientific Recent Developments
- 4.5 WEIGAO
- 4.5.1 WEIGAO Company Information
- 4.5.2 WEIGAO Business Overview
- 4.5.3 WEIGAO Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 WEIGAO Recombinant Human BMP-2 Product Portfolio
- 4.5.5 WEIGAO Recent Developments
- 4.6 Shanghai Zhong Qiao Xin Zhou Biotechnology
- 4.6.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
- 4.6.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
- 4.6.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio
- 4.6.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
- 4.7 Shanghai NovoPro
- 4.7.1 Shanghai NovoPro Company Information
- 4.7.2 Shanghai NovoPro Business Overview
- 4.7.3 Shanghai NovoPro Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio
- 4.7.5 Shanghai NovoPro Recent Developments
- 4.8 HANGZHOU JIUYUAN GENE ENGINEERIN
- 4.8.1 HANGZHOU JIUYUAN GENE ENGINEERIN Company Information
- 4.8.2 HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview
- 4.8.3 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio
- 4.8.5 HANGZHOU JIUYUAN GENE ENGINEERIN Recent Developments
- 4.9 Beijing Baiaolaibo Technology
- 4.9.1 Beijing Baiaolaibo Technology Company Information
- 4.9.2 Beijing Baiaolaibo Technology Business Overview
- 4.9.3 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio
- 4.9.5 Beijing Baiaolaibo Technology Recent Developments
- 4.10 STEMCELL Technologies
- 4.10.1 STEMCELL Technologies Company Information
- 4.10.2 STEMCELL Technologies Business Overview
- 4.10.3 STEMCELL Technologies Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio
- 4.10.5 STEMCELL Technologies Recent Developments
- 4.11 Sigma Aldrich
- 4.11.1 Sigma Aldrich Company Information
- 4.11.2 Sigma Aldrich Business Overview
- 4.11.3 Sigma Aldrich Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sigma Aldrich Recombinant Human BMP-2 Product Portfolio
- 4.11.5 Sigma Aldrich Recent Developments
- 4.12 Proteintech
- 4.12.1 Proteintech Company Information
- 4.12.2 Proteintech Business Overview
- 4.12.3 Proteintech Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Proteintech Recombinant Human BMP-2 Product Portfolio
- 4.12.5 Proteintech Recent Developments
- 4.13 CUSABIO TECHNOLOGY
- 4.13.1 CUSABIO TECHNOLOGY Company Information
- 4.13.2 CUSABIO TECHNOLOGY Business Overview
- 4.13.3 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio
- 4.13.5 CUSABIO TECHNOLOGY Recent Developments
- 4.14 Cgbio
- 4.14.1 Cgbio Company Information
- 4.14.2 Cgbio Business Overview
- 4.14.3 Cgbio Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Cgbio Recombinant Human BMP-2 Product Portfolio
- 4.14.5 Cgbio Recent Developments
- 4.15 Cell Guidance Systems
- 4.15.1 Cell Guidance Systems Company Information
- 4.15.2 Cell Guidance Systems Business Overview
- 4.15.3 Cell Guidance Systems Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio
- 4.15.5 Cell Guidance Systems Recent Developments
- 4.16 Biomol GmbH
- 4.16.1 Biomol GmbH Company Information
- 4.16.2 Biomol GmbH Business Overview
- 4.16.3 Biomol GmbH Recombinant Human BMP-2 Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Biomol GmbH Recombinant Human BMP-2 Product Portfolio
- 4.16.5 Biomol GmbH Recent Developments
5 Global Recombinant Human BMP-2 Market Scenario by Region
- 5.1 Global Recombinant Human BMP-2 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Recombinant Human BMP-2 Sales by Region: 2021-2032
- 5.2.1 Global Recombinant Human BMP-2 Sales by Region: 2021-2026
- 5.2.2 Global Recombinant Human BMP-2 Sales by Region: 2027-2032
- 5.3 Global Recombinant Human BMP-2 Revenue by Region: 2021-2032
- 5.3.1 Global Recombinant Human BMP-2 Revenue by Region: 2021-2026
- 5.3.2 Global Recombinant Human BMP-2 Revenue by Region: 2027-2032
- 5.4 North America Recombinant Human BMP-2 Market Facts & Figures by Country
- 5.4.1 North America Recombinant Human BMP-2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Recombinant Human BMP-2 Sales by Country (2021-2032)
- 5.4.3 North America Recombinant Human BMP-2 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Recombinant Human BMP-2 Market Facts & Figures by Country
- 5.5.1 Europe Recombinant Human BMP-2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Recombinant Human BMP-2 Sales by Country (2021-2032)
- 5.5.3 Europe Recombinant Human BMP-2 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Recombinant Human BMP-2 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Recombinant Human BMP-2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Recombinant Human BMP-2 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Recombinant Human BMP-2 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Recombinant Human BMP-2 Market Facts & Figures by Country
- 5.7.1 South America Recombinant Human BMP-2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Recombinant Human BMP-2 Sales by Country (2021-2032)
- 5.7.3 South America Recombinant Human BMP-2 Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Recombinant Human BMP-2 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Recombinant Human BMP-2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Recombinant Human BMP-2 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Recombinant Human BMP-2 Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Recombinant Human BMP-2 Sales by Type (2021-2032)
- 6.1.1 Global Recombinant Human BMP-2 Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Recombinant Human BMP-2 Sales Market Share by Type (2021-2032)
- 6.2 Global Recombinant Human BMP-2 Revenue by Type (2021-2032)
- 6.2.1 Global Recombinant Human BMP-2 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Recombinant Human BMP-2 Revenue Market Share by Type (2021-2032)
- 6.3 Global Recombinant Human BMP-2 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Recombinant Human BMP-2 Sales by Application (2021-2032)
- 7.1.1 Global Recombinant Human BMP-2 Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Recombinant Human BMP-2 Sales Market Share by Application (2021-2032)
- 7.2 Global Recombinant Human BMP-2 Revenue by Application (2021-2032)
- 7.2.1 Global Recombinant Human BMP-2 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Recombinant Human BMP-2 Revenue Market Share by Application (2021-2032)
- 7.3 Global Recombinant Human BMP-2 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Recombinant Human BMP-2 Value Chain Analysis
- 8.1.1 Recombinant Human BMP-2 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Recombinant Human BMP-2 Production Mode & Process
- 8.2 Recombinant Human BMP-2 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Recombinant Human BMP-2 Distributors
- 8.2.3 Recombinant Human BMP-2 Customers
9 Global Recombinant Human BMP-2 Analyzing Market Dynamics
- 9.1 Recombinant Human BMP-2 Industry Trends
- 9.2 Recombinant Human BMP-2 Industry Drivers
- 9.3 Recombinant Human BMP-2 Industry Opportunities and Challenges
- 9.4 Recombinant Human BMP-2 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst